Patents by Inventor Omid Khorram

Omid Khorram has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING FIBROIDS
    Publication number: 20220010028
    Abstract: The present disclosure relates generally to compositions and methods for treating fibroid in a patient in need thereof, which entails administering to the patient an effective amount of an agent that inhibits the expression or activity of TDO2 or IDO1.
    Type: Application
    Filed: July 1, 2021
    Publication date: January 13, 2022
    Inventors: Omid Khorram, Tsai-Der Chuang
  • Methods of modulating miRNA levels and compositions for use in the same
    Patent number: 10517842
    Abstract: Methods of modulating a miRNA level, such as a miR-29c and/or miR-200c level, in a cell are provided. Aspects of the methods include contacting the cell with an anti-fibrotic miRNA modulating active agent, such as a tranilast active agent. Also provided are compositions for use in practicing the methods. The methods and compositions find use in a variety of applications, including the treatment of fibrotic disorders, such as a uterine leiomyoma.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: December 31, 2019
    Assignee: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
    Inventors: Omid Khorram, Tsai-Der Chuang
  • Methods of Modulating miRNA Levels and Compositions for Use in the Same
    Publication number: 20180263941
    Abstract: Methods of modulating a miRNA level, such as a miR-29c and/or miR-200c level, in a cell are provided. Aspects of the methods include contacting the cell with an anti-fibrotic miRNA modulating active agent, such as a tranilast active agent. Also provided are compositions for use in practicing the methods. The methods and compositions find use in a variety of applications, including the treatment of fibrotic disorders, such as a uterine leiomyoma.
    Type: Application
    Filed: March 14, 2018
    Publication date: September 20, 2018
    Inventors: Omid Khorram, Tsai-Der Chuang